Night vision composition
US8979809B2 · kind B2 · utility
16Cited by
28References
21Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 12, 2004 |
| Grant date | Mar 17, 2015 |
| Priority date | — |
| Expiry date | Mar 12, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for optimizing pupil size in individuals suffering from excessive pupillary dilation in dim light as well as through medication is disclosed. Alpha 1 antagonist is applied in an eye drop formulation to the eye, resulting in reduced pupil size in dim light, but less reduction in pupil size in bright light.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.